Bisperoxovandium (pyridin-2-squaramide) targets both PTEN and ERK1/2 to confer neuroprotection.
Zhang ZF, Chen J, Han X, Zhang Y, Liao HB, Lei RX, Zhuang Y, Wang ZF, Li Z, Chen JC, Liao WJ, Zhou HB, Liu F, Wan Q.
Zhang ZF, et al. Among authors: liao hb, liao wj.
Br J Pharmacol. 2017 Apr;174(8):641-656. doi: 10.1111/bph.13727. Epub 2017 Feb 27.
Br J Pharmacol. 2017.
PMID: 28127755
Free PMC article.